HCV COMBINATION THERAPY

Aspects of this invention include methods comprising administering a combination of a Compound (1) below, including particular crystalline forms thereof and pharmaceutically acceptable salts thereof, with at least one further selected HCV inhibiting compound as described herein for the treatment of...

Full description

Saved in:
Bibliographic Details
Main Author KUKOLJ GEORGE
Format Patent
LanguageEnglish
Korean
Published 22.10.2012
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:Aspects of this invention include methods comprising administering a combination of a Compound (1) below, including particular crystalline forms thereof and pharmaceutically acceptable salts thereof, with at least one further selected HCV inhibiting compound as described herein for the treatment of Hepatitis C Viral (HCV) infection. The methods can be conducted by administering the Compound (1) and the at least one further selected HCV inhibiting compound separately or together, including as a regimen of treatment.
Bibliography:Application Number: KR20127014548